Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.
2.

Beta-amyloid, neuronal death and Alzheimer's disease.

Carter J, Lippa CF.

Curr Mol Med. 2001 Dec;1(6):733-7. Review.

PMID:
11899259
3.

Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease.

Klein WL, Stine WB Jr, Teplow DB.

Neurobiol Aging. 2004 May-Jun;25(5):569-80. Review.

4.

Structure-function implications in Alzheimer's disease: effect of Abeta oligomers at central synapses.

Cerpa W, Dinamarca MC, Inestrosa NC.

Curr Alzheimer Res. 2008 Jun;5(3):233-43. Review.

PMID:
18537540
5.

Emerging beta-amyloid therapies for the treatment of Alzheimer's disease.

Conway KA, Baxter EW, Felsenstein KM, Reitz AB.

Curr Pharm Des. 2003;9(6):427-47. Review.

PMID:
12570807
6.

Always around, never the same: pathways of amyloid beta induced neurodegeneration throughout the pathogenic cascade of Alzheimer's disease.

Hoozemans JJ, Chafekar SM, Baas F, Eikelenboom P, Scheper W.

Curr Med Chem. 2006;13(22):2599-605. Review.

PMID:
17017913
8.

Alzheimer's disease-associated neurotoxic mechanisms and neuroprotective strategies.

Pereira C, Agostinho P, Moreira PI, Cardoso SM, Oliveira CR.

Curr Drug Targets CNS Neurol Disord. 2005 Aug;4(4):383-403. Review.

PMID:
16101556
9.

Molecular mechanisms initiating amyloid beta-fibril formation in Alzheimer's disease.

Kirkitadze MD, Kowalska A.

Acta Biochim Pol. 2005;52(2):417-23. Epub 2005 May 31. Review.

10.
11.

Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models.

Götz J, Schild A, Hoerndli F, Pennanen L.

Int J Dev Neurosci. 2004 Nov;22(7):453-65. Review.

PMID:
15465275
12.

Clusterin and Alzheimer's disease.

Calero M, Rostagno A, Frangione B, Ghiso J.

Subcell Biochem. 2005;38:273-98. Review.

PMID:
15709484
13.

Neuroprotective approaches in experimental models of beta-amyloid neurotoxicity: relevance to Alzheimer's disease.

Harkany T, Hortobágyi T, Sasvári M, Kónya C, Penke B, Luiten PG, Nyakas C.

Prog Neuropsychopharmacol Biol Psychiatry. 1999 Aug;23(6):963-1008. Review.

PMID:
10621945
14.

Vicious cycles within the neuropathophysiologic mechanisms of Alzheimer's disease.

Standridge JB.

Curr Alzheimer Res. 2006 Apr;3(2):95-108. Review.

PMID:
16611010
15.

Amyloid binding ligands as Alzheimer's disease therapies.

Lee VM.

Neurobiol Aging. 2002 Nov-Dec;23(6):1039-42. Review.

PMID:
12470800
16.

Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: a role for intraneuronal amyloid.

Giménez-Llort L, Blázquez G, Cañete T, Johansson B, Oddo S, Tobeña A, LaFerla FM, Fernández-Teruel A.

Neurosci Biobehav Rev. 2007;31(1):125-47. Epub 2006 Oct 20. Review.

PMID:
17055579
17.

Amyloid associated proteins in Alzheimer's and prion disease.

Veerhuis R, Boshuizen RS, Familian A.

Curr Drug Targets CNS Neurol Disord. 2005 Jun;4(3):235-48. Review.

PMID:
15975027
18.

Synaptic plasticity in animal models of early Alzheimer's disease.

Rowan MJ, Klyubin I, Cullen WK, Anwyl R.

Philos Trans R Soc Lond B Biol Sci. 2003 Apr 29;358(1432):821-8. Review.

19.

Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death.

Butterfield DA, Castegna A, Lauderback CM, Drake J.

Neurobiol Aging. 2002 Sep-Oct;23(5):655-64. Review.

PMID:
12392766
20.

Supplemental Content

Support Center